From Resin to Commercial Empire: Unpacking the Stories of Purolite, Ecolab, and Nalco

1. Completing the Most Critical Technical Puzzle. Ecolab’s traditional strength lies in the 'peripheral management of water systems'—for example, preventing scale formation in cooling water, inhibiting boiler corrosion, and suppressing bacterial growth in pipelines. It helps customers optimize these systems using specialty chemicals combined with intelligent monitoring (notably its renowned 3D TRASAR™ technology). However, one key link has always remained outside its direct control: core separation and purification. Purolite’s chromatography resins and adsorption resins precisely address this bottleneck in high-end manufacturing sectors such as biopharmaceuticals and semiconductors. Acquiring Purolite enables Ecolab to step directly into the heart of production processes within these high-value-added industries—evolving from a 'back-office service provider' into a 'core process partner'. 2. Building a Complete 'Water + Process' Closed Loop. Imagine this: Ecolab first treats your incoming water (Nalco’s domain), then Purolite’s resins actively participate in purifying pharmaceuticals or isolating target products during your manufacturing process; finally, wastewater returns to Ecolab for reuse or compliant discharge treatment. Once this closed loop is fully operational, customers become deeply embedded—and highly sticky—within this integrated ecosystem. 3. Optimizing Business Structure and Profitability. Ecolab’s traditional service model relies on service contracts and chemical consumption. In contrast, Purolite’s premium resins are high-margin, repeat-purchase consumables; once integrated into a customer’s production process, they generate steady, recurring cash flow—a highly attractive asset for any publicly listed company. Thus, the logic behind this acquisition is exceptionally coherent: Ecolab needs Purolite’s technological depth and access to premium markets, while Purolite benefits from Ecolab’s global network, customer base, and platform capabilities—truly a win-win arrangement. IV. Ecolab’s Water Treatment Core: Nalco Water At this point, we must highlight Nalco Water—the subsidiary under Ecolab that truly handles water treatment operations. Many people confuse the relationships among Ecolab, Nalco, and Purolite. Here’s a simple clarification: ・Ecolab is the parent conglomerate. ・Nalco is Ecolab’s dedicated water treatment brand, primarily serving industrial and municipal sectors. Its core competencies lie in specialty chemicals, intelligent monitoring, and service delivery. ・Purolite, post-acquisition, operates as an independent business unit focused on resin materials and separation/purification technologies. Nalco’s flagship technology is the aforementioned 3D TRASAR™. What does it entail? Sensors are installed across your cooling water systems, boilers, and reverse osmosis membranes to monitor parameters—including scaling, corrosion, microbial activity, and chemical concentration—24/7 in real time. Algorithms then automatically adjust chemical dosing for precise control. Put simply, it equips water systems with an 'intelligent driving system'. Nalco offers a comprehensive product portfolio: from corrosion- and scale-inhibiting PermaCare® series, to various softeners and filters (e.g., UltraTreat™, UltraSand™), and customized solutions for data center liquid cooling and semiconductor facility management—covering virtually every facet of industrial water treatment. V. Their Interrelationship In summary, the relationship among these three entities can be characterized as follows: ・Purolite provides the foundational 'materials layer', solving the question of 'what to use for separation'. Its technological moat in high-end separation and purification is exceptionally high. ・Nalco delivers the 'system control layer', addressing 'how to ensure stable and efficient operation of water systems'. Its intelligent monitoring and chemical solutions enjoy strong industry reputation. ・Ecolab, as the parent group, integrates these two capabilities—and layers on top its expertise in cleaning, disinfection, food safety, and infection prevention—to form a comprehensive, cross-industry solution platform.

Global Low-Value Consumables Giant Makes Another Acquisition to Enhance OEM Capabilities

In 2022, Medline acquired ASID BONZ, Germany’s leading hospital supplier. In 2021, ASID BONZ generated over €30 million in revenue and served more than 1,100 hospitals across Germany. As a leading medical supplies distributor, Medline not only delivers high-quality products to its customers but also assists them in managing their supply chains and improving the operational efficiency of healthcare systems. During the height of the pandemic in 2020, Medline supplied tens of thousands of N95 masks, hand sanitizers, and other protective products daily. The company opened dozens of distribution centers across the U.S.—each exceeding one million square feet—and expanded production at its Litchfield Springs facility to manufacture 36 million masks per month. Number of Global Distribution Centers (left) and Total Square Footage of U.S. Distribution Centers (right) Medline’s core business focuses on low-value consumables—products highly susceptible to price fluctuations across both upstream and downstream supply chain segments. As market competition intensifies, downstream customers’ bargaining power continues to rise; meanwhile, upstream production costs have surged rapidly due to policy-related factors. Consequently, in 2021, Medline began seeking potential buyers. In June 2021, Medline announced that Blackstone—the 'King of Capital'—Carlyle Group, and other prominent private equity firms had agreed to acquire approximately 75% of the company for roughly $30 billion. The company did not disclose specific reasons for the sale; however, it may reflect strategic considerations anticipating economic recession in the post-pandemic era—allowing Medline to secure a relatively high valuation in 2021. Following the acquisition, the company remains led by the Mills family, which retains its position as the largest single shareholder; the management team remains unchanged. Medline stated it will leverage the new resources from this transaction to expand its product portfolio, accelerate international expansion, and invest in infrastructure to strengthen its global supply chain—thereby optimizing global resource allocation, enhancing cost control and production efficiency, and reinforcing Medline’s core competitiveness. According to Medical Design & Outsourcing’s 2021 Global Top 100 Medical Device Companies ranking, Medline reported $17.5 billion in revenue for fiscal year 2020, placing sixth globally. Amid the global surge in COVID-19 cases, the company added over 230 new customers in 2021, and its sales revenue rose to over $20 billion in 2022. About Ecolab Ecolab (NYSE: ECL), with over a century of history, is a publicly traded company listed on the New York Stock Exchange. As a global leader in sustainability, Ecolab delivers water, hygiene, and infection prevention solutions and services to protect people and precious natural resources. Guided by innovation, it provides science-based, integrated solutions, data-driven insights, and world-class service—helping customers worldwide improve food safety, maintain clean and safe environments, optimize water and energy usage, and enhance operational efficiency. Ecolab offers end-to-end OEM services for the healthcare sector—from design through delivery—collaborating with clients to develop customized solutions, then elevating them to new levels through optimization, design, and rigorous testing.

Ecolab Director David MacLennan Buys $184,875 in Company Stock

16 hours ago

Ecolab director David MacLennan purchased 600 shares worth $184,875 at $308.125 per share. This transaction follows strong third-quarter earnings, with adjusted EPS beating estimates and organic sales rising 7%.

Investing.com Canada

Ecolab Director David MacLennan Buys $184,875 in Company Stock

Investing.com India

2026-06-10

Ecolab Inc. Insider Trading Activity

2026-06-10

Ecolab Co-COO Sells Shares Worth Over $2.6M

2026-06-11

Ecolab Director Purchases 7,750 Shares in Open-Market Transaction

2026-06-12

Michel Doukeris Purchases Shares of Ecolab Inc (ECL)